Author

M. Wimsett

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. H. Cox· 1 shared E. C. Arvin· 1 shared J. S. Blackburn· 1 shared M. A. Al-Hamaly· 1 shared M. G. Haney· 1 shared S. Sampathi· 1 shared W. Zhang· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. H. Cox

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Zebrafish Drug Screening Identifies Erlotinib as an Inhibitor of Wnt/β-Catenin Signaling and Self-Renewal in T-cell Acute Lymphoblastic Leukemia

M. A. Al-Hamaly, A. H. Cox, M. G. Haney, W. Zhang, E. C. Arvin, S. Sampathi, M. Wimsett, J. S. Blackburn

This study identifies Erlotinib as a Wnt/β-catenin inhibitor effective in zebrafish and human cells, reducing leukemia-initiating cell self-renewal and disease progression.

bioRxiv · Aug 28, 2023Cancer Biology